We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Top Sells

Rank Stock Value
1
BRCM
BROADCOM CORP CL-A
BRCM
+$43M
2
PCP
PRECISION CASTPARTS CORP
PCP
+$42.1M
3
GMCR
KEURIG GREEN MTN INC
GMCR
+$17.2M
4
CB icon
Chubb
CB
+$13.7M
5
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
+$13.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPX
2851
DELISTED
Marine Products Corp
MPX
$128K ﹤0.01%
16,886
– –
EVH icon
2852
Evolent Health
EVH
$350M
$127K ﹤0.01%
12,010
+455
+4% +$4.7K
HBIO icon
2853
Harvard Bioscience
HBIO
$28.5M
$127K ﹤0.01%
4,206
+473
+13% +$13.4K
WTI icon
2854
W&T Offshore
WTI
$509M
$126K ﹤0.01%
57,702
+260
+0.5% +$528
CASC
2855
DELISTED
Cascadian Therapeutics, Inc.
CASC
$125K ﹤0.01%
16,409
+29
+0.2% +$223
FLXN
2856
DELISTED
Flexion Therapeutics, Inc.
FLXN
$124K ﹤0.01%
13,488
+125
+0.9% +$1.52K
AEG icon
2857
Aegon
AEG
$13.9B
$123K ﹤0.01%
31,043
+5,426
+21% +$21K
LCTX icon
2858
Lineage Cell Therapeutics
LCTX
$279M
$123K ﹤0.01%
49,047
-3,810
-7% -$8.5K
GLBL
2859
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$123K ﹤0.01%
51,670
+4,785
+10% +$16.6K
CJES
2860
DELISTED
C&J ENERGY SVCS LTD
CJES
$122K ﹤0.01%
86,458
+7,950
+10% +$16.9K
PZN
2861
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$120K ﹤0.01%
15,915
– –
IO
2862
DELISTED
ION Geophysical Corporation
IO
$120K ﹤0.01%
14,883
+1,067
+8% +$6.22K
FUEL
2863
DELISTED
Rocket Fuel Inc.
FUEL
$119K ﹤0.01%
37,771
+3,730
+11% +$12.1K
EVDY
2864
DELISTED
Everyday Health, Inc.
EVDY
$119K ﹤0.01%
21,317
+210
+1% +$1.03K
TVRD
2865
Tvardi Therapeutics
TVRD
$19M
$118K ﹤0.01%
529
+10
+2% +$2.99K
GEN
2866
DELISTED
Genesis Healthcare, Inc.
GEN
$115K ﹤0.01%
49,496
+2,645
+6% +$5.98K
EPM icon
2867
Evolution Petroleum
EPM
$127M
$114K ﹤0.01%
23,489
– –
LRMR icon
2868
Larimar Therapeutics
LRMR
$427M
$114K ﹤0.01%
1,424
– –
TLYS icon
2869
Tilly's
TLYS
$130M
$114K ﹤0.01%
17,032
+1,600
+10% +$11K
BREW
2870
DELISTED
Craft Brew Alliance, Inc.
BREW
$114K ﹤0.01%
13,907
+960
+7% +$7.81K
SGM
2871
DELISTED
Stonegate Mortgage Corporation
SGM
$113K ﹤0.01%
19,655
+1,680
+9% +$7.49K
PSV
2872
DELISTED
Hermitage Offshore Services Ltd.
PSV
$112K ﹤0.01%
2,502
+268
+12% +$11.8K
SNMX
2873
DELISTED
Senomyx, Inc.
SNMX
$112K ﹤0.01%
43,053
– –
OSIR
2874
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$111K ﹤0.01%
19,474
+290
+2% +$2.02K
IPI icon
2875
Intrepid Potash
IPI
$456M
$110K ﹤0.01%
9,866
+283
+3% +$5.11K
113 114
115
116 117

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.